A brief note on the random-effects meta-analysis model and its relationship to other models.

J Clin Epidemiol

Knowledge Translation Program, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, 209 Victoria Street, Toronto, Ontario, Canada; Institute for Health Policy, Management, and Evaluation, University of Toronto, 155 College Street, Toronto, Ontario, Canada.

Published: October 2024


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Meta-analysis is a statistical method for combining quantitative results across studies. A fundamental decision in undertaking a meta-analysis is choosing an appropriate model for analysis. This is the second of two companion articles which have the joint aim of describing the different meta-analysis models. In the first article, we focused on the common-effect (also known as fixed-effect [singular]) model, and in this article, we focus on the random-effects model. We describe the key assumptions underlying the random-effects model, how it is related to the common-effect and fixed-effects [plural] models, and present some of the arguments for selecting one model over another. We outline some of the methods for fitting a random-effects model. Finally, we present an illustrative example to demonstrate how the results can differ depending on the chosen model and method. Understanding the assumptions of the different meta-analysis models, and the questions they address, is critical for meta-analysis model selection and interpretation.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jclinepi.2024.111492DOI Listing

Publication Analysis

Top Keywords

random-effects model
12
model
9
meta-analysis model
8
meta-analysis models
8
meta-analysis
6
note random-effects
4
random-effects meta-analysis
4
model relationship
4
models
4
relationship models
4

Similar Publications

Objective: Posttraumatic stress disorder (PTSD) and posttraumatic growth (PTG) can co-occur in individuals affected by the COVID-19 pandemic; however, the nature of their relationship remains inconclusive. The present study aimed to explore the PTSD-PTG relationship during the COVID-19 pandemic and possible moderators between them with meta-analysis approach.

Method: A systematic search of six databases-Web of Science, CNKI, PubMed, APA PsycInfo, ProQuest, and Wanfang-was conducted for studies published between December 2019 (the first time COVID-19 was confirmed) and March 2023, and 27 studies were available (19,998 participants).

View Article and Find Full Text PDF

Importance: Youth living with type 1 diabetes (T1D) are increasingly choosing automated insulin delivery (AID) systems to manage their blood glucose. Few systematic reviews meta-analyzing results from randomized clinical trials (RCTs) are available to guide decision-making.

Objective: To study the association of prolonged AID system use in an outpatient setting with measures of glucose management and quality of life in youth with T1D.

View Article and Find Full Text PDF

PurposeTo summarize the currently available evidence regarding the effectiveness and safety of extracorporeal membrane oxygenation (ECMO) cannulation performed by intensivists.MethodsWe conducted a systematic search of MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials for studies of any design in which patients underwent ECMO cannulation by intensivists. The search was updated on Dec 15, 2024.

View Article and Find Full Text PDF

Background: Uncertainty exists regarding the health-related quality of life (HRQL) benefits of food allergen oral immunotherapy (OIT). Up-to-date meta-analyses incorporating HRQL data from recent randomised trials are lacking.

Methods: Systematic searches of MEDLINE, Embase, CENTRAL and Google Scholar were conducted for food OIT randomised trials (versus any comparator) that measured HRQL with a validated instrument (27 July 2023).

View Article and Find Full Text PDF

Background: Opioid use disorder (OUD) is commonly treated in specialized care settings with long-acting opioid agonists, also known as opioid agonist therapy, or OAT. Despite the rise in opioid use globally and evidence for a 50% reduction in mortality when OAT is employed, the proportion of people with OUD receiving OAT remains small. One initiative to improve the access and uptake of OAT could be to offer OAT in a primary care setting; primary care clinics are more numerous, might reduce the visibility and potential stigma of receiving treatment for OUD, and may facilitate the care of other medical conditions that are unrelated to OUD.

View Article and Find Full Text PDF